Cargando…

Low sclerostin levels after long-term remission of acromegaly

PURPOSE: Bone health is compromised in acromegaly resulting in vertebral fractures (VFs), regardless of biochemical remission. Sclerostin is a negative inhibitor of bone formation and is associated with increased fracture risk in the general population. Therefore, we compared sclerostin concentratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Claessen, Kim M. J. A., Pelsma, Iris C. M., Kroon, Herman M., van Lierop, Antoon H., Pereira, Alberto M., Biermasz, Nienke R., Appelman-Dijkstra, Natasha M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763730/ https://www.ncbi.nlm.nih.gov/pubmed/34448099 http://dx.doi.org/10.1007/s12020-021-02850-7

Ejemplares similares

Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly
por: van Trigt, Victoria R., et al.
Publicado: (2021)

Clinical and radiographic assessment of peripheral joints in controlled acromegaly
por: Pelsma, Iris C. M., et al.
Publicado: (2022)

Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016)

Nanomedicines in the treatment of acromegaly: focus on pegvisomant
por: Roelfsema, Ferdinand, et al.
Publicado: (2006)

Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients
por: Biermasz, Nienke R., et al.
Publicado: (2007)

Therapeutic options in the management of acromegaly: focus on lanreotide Autogel(®)
por: Roelfsema, Ferdinand, et al.
Publicado: (2008)

Serum sclerostin levels in osteoporotic fracture patients
por: Gorter, Erwin A., et al.
Publicado: (2022)

Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly
por: van der Klaauw, Agatha A., et al.
Publicado: (2009)

Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need
por: van Trigt, Victoria R., et al.
Publicado: (2023)

Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
por: Roelfsema, Ferdinand, et al.
Publicado: (2011)

State of the Art of Patient-reported Outcomes in Acromegaly or GH Deficiency: A Systematic Review and Meta-analysis
por: van der Meulen, Merel, et al.
Publicado: (2021)

Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
por: Geraedts, Victor J., et al.
Publicado: (2017)

Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers
por: Shishkov, Savi R, et al.
Publicado: (2022)

SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial
por: Yang, Yuebo, et al.
Publicado: (2019)

Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease
por: van der Werff, Steven J.A., et al.
Publicado: (2014)

Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
por: Sala, E., et al.
Publicado: (2021)

Improvement in Symptoms and Health-Related Quality of Life in Acromegaly Patients: A Systematic Review and Meta-Analysis
por: Broersen, Leonie H A, et al.
Publicado: (2020)

Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient’s Perspective
por: Claessen, Kim M. J. A., et al.
Publicado: (2021)

MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2023)

Association of pre- and postoperative αKlotho levels with long-term remission after pituitary surgery for acromegaly
por: Neidert, Marian Christoph, et al.
Publicado: (2022)

Long‐term effects of glucocorticoid excess on the brain
por: Dekkers, Alies J., et al.
Publicado: (2022)

Chiasmal herniation following treatment of pituitary macroadenoma
por: Tabak, Marjolein, et al.
Publicado: (2020)

Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study
por: Pelsma, Iris C. M., et al.
Publicado: (2020)

How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
por: van Esdonk, Michiel J., et al.
Publicado: (2018)

MON-327 Soluble Alpha Klotho and IGF-I Before Surgery as Prognostic Factors to Acromegaly Long-term Remission
por: de Oliveira Longo Schweizer, Junia Ribeiro, et al.
Publicado: (2020)

Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
por: Coopmans, Eva C, et al.
Publicado: (2021)

RF13 | PMON159 Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly: MPOWERED Trial Open-Label Extension Phase
por: Fleseriu, Maria, et al.
Publicado: (2022)

Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study
por: Lucassen, Eliane A., et al.
Publicado: (2017)

MON-310 Factors Associated with Remission After Surgery for Acromegaly
por: Cunha, Clara, et al.
Publicado: (2020)

Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
por: van Trigt, Victoria R., et al.
Publicado: (2023)

Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?
por: van Trigt, Victoria R., et al.
Publicado: (2023)

THU060 Time To First Remission, Medical Therapy And Survival In Acromegaly: UK Acromegaly Register (UKAR) Study
por: Deshmukh, Harshal, et al.
Publicado: (2023)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Higher Plasma Sclerostin and Lower Wnt Signaling Gene Expression in White Adipose Tissue of Prediabetic South Asian Men Compared with White Caucasian Men
por: Janssen, Laura G.M., et al.
Publicado: (2020)

Development and Interpretation of Multiple Machine Learning Models for Predicting Postoperative Delayed Remission of Acromegaly Patients During Long-Term Follow-Up
por: Dai, Congxin, et al.
Publicado: (2020)

SAT-LB60 Discordant Biological Parameters of Remission in Acromegaly Do Not Increase the Risk of Hypertension or Diabetes: A Study With the Liege Acromegaly Survey Database
por: Amodru, Vincent, et al.
Publicado: (2020)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Acromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy
por: Sanz-Sapera, E, et al.
Publicado: (2019)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

FRI299 Efficacy And Safety Of Endoscopic Transsphenoidal Resection For Prolactinoma: A Retrospective Case-series
por: Zandbergen, Ingrid M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uci4n13kp5gjjg2gvqujq9unp1